11.2: The Food and Drug Administration (FDA)

Quality and Regulatory Compliance in Bioscience · LibreTexts

0%

Contents

    Text

    Size
    100%
    Theme
    Typeface
    Line length
    Spacing

    Read aloud

    How

    Speed: 1×
    Light up
    Highlight

    Symbols: Mulberry Symbols, © 2018–2026 Steve Lee, CC BY-SA 4.0 (licence, the set), the site's own copies.

    From LibreTexts, under CC BY-SA 4.0, as the source states it; its equations are written in TeX, which the PDF shows typeset. This page at LibreTexts.

    11.2: The Food and Drug Administration (FDA)

    FDA Organization

    The U.S. Food and Drug Administration (FDA) is part of the U.S. Department of Health and Human Services. It regulates a wide range of products, including human and animal drugs, many biological products, medical devices, most foods, cosmetics, tobacco products, and certain products that emit radiation.

    What the FDA doesHow the FDA carries out federal law.png

    The FDA carries out laws passed by Congress. Three parts of its work are especially relevant to biotechnology. 

    • Rulemaking. The FDA issues regulations under authority granted by Congress. These regulations explain what companies must do to comply with federal law.

    • Application review. FDA specialists evaluate the evidence companies submit about their products. The agency uses that evidence to make decisions such as whether to approve a new drug.

    • Investigation and enforcement. FDA staff inspect facilities, review records, and collect samples for testing. The agency uses the findings to decide whether further action is needed.

    How the FDA organizes its work

    The Office of the Commissioner leads the agency and coordinates work that involves multiple centers and offices. Support teams handle functions such as information technology, budgeting, purchasing, human resources, and records management.

    Three centers oversee medical products that biotechnology students are likely to encounter.

    FDA center Examples of products it oversees
    Center for Drug Evaluation and Research (CDER) Prescription and over-the-counter drugs, including many therapeutic proteins
    Center for Biologics Evaluation and Research (CBER) Vaccines, blood products, and cell and gene therapies
    Center for Devices and Radiological Health (CDRH) Medical devices, including many diagnostic tests, and certain products that emit radiation

    Other parts of the FDA focus on different product areas. The Center for Tobacco Products oversees tobacco products within the FDA’s authority. The Human Foods Program (HFP) oversees the agency’s work on human food safety and nutrition. When the program launched on October 1, 2024, it brought together work previously handled by the Center for Food Safety and Applied Nutrition (CFSAN) and other FDA offices.

    The Office of Inspections and Investigations (OII) leads the FDA’s field work. Older documents may refer to it as the Office of Regulatory Affairs (ORA), its name before the October 2024 reorganization. OII staff inspect facilities, investigate possible violations, and review products entering the United States. They work with FDA centers, programs, and laboratories to gather evidence and respond to product safety problems.

    For example, during an inspection of a vaccine manufacturing site, an FDA investigator may review batch records and ask how the company handled an unexpected test result. The investigator’s findings can help specialists at CBER evaluate the problem and determine what follow-up is needed. If you need to identify the office responsible for a particular product or issue, check the FDA’s current organization pages.


    This page titled 11.2: The Food and Drug Administration (FDA) was last modified on Tue, 03 Nov 2026 07:56:47 GMT and is shared under a CC BY-SA 4.0 license and was authored, remixed, and/or curated by Emalee MacKenzie.